Improving Keloids Using Targeted Ultraviolet-B Irradiation

Improving Keloids Using Targeted Ultraviolet-B Irradiation

Treatment of keloids with targeted Ultraviolet-Beta (UVB) radiation will improve the clinical appearance and induration of lesions.

Inclusion Criteria:

• Participants must be 18 years old or over
• Participants must have a diagnosis of keloid
• No treatment with topical or intralesional steroids for 1 month prior to study

Exclusion Criteria:

• Patients who are unable to provide informed consent
• A history of photosensitivity, lupus erythematosus, porphyria or current use of a known photosensitizing drug
• Unwillingness to stop with topical or intralesional steroids for 1 month prior to study
• A history of malignant melanoma
• A history of radiation therapy to area of interest
• Subjects who self-report that they are pregnant or nursing